Structure |
Chemical Name |
CAS |
MF |
![(E)-1-(4-(2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)ethanone](/CAS/20150408/GIF/935272-10-9.gif) |
(E)-1-(4-(2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)ethanone |
935272-10-9 |
C18H20N4OS |
![2-(thiophen-3-yl)ethyl 4-methylbenzenesulfonate](/CAS/20180808/GIF/40412-09-7.gif) |
2-(thiophen-3-yl)ethyl 4-methylbenzenesulfonate |
40412-09-7 |
C13H14O3S2 |
![4-Nitrophenyl 5-chlorothiophene-2-carboxylate](/CAS/20150408/GIF/1450877-56-1.gif) |
4-Nitrophenyl 5-chlorothiophene-2-carboxylate |
1450877-56-1 |
C11H6ClNO4S |
![Olaparib iMpurity B](/) |
Olaparib iMpurity B |
|
|
![Posaconazole iMpurity 6](/CAS/20210111/GIF/2185472-85-7.gif) |
Posaconazole iMpurity 6 |
2185472-85-7 |
C30H35N5O3 |
![Everolimus Isomer C](/) |
Everolimus Isomer C |
|
|
![3-Deschloro-4-Desfluoro-4-Chloro-3-Fluorogefitinib](/CAS/20180808/GIF/1603814-04-5.gif) |
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluorogefitinib |
1603814-04-5 |
C22H24ClFN4O3 |
![Brivaracetam (Racemate)](/CAS/20210111/GIF/357335-87-6.gif) |
Brivaracetam (Racemate) |
357335-87-6 |
C11H20N2O2 |
![Donepezil Impurity 2](/CAS/20181212/GIF/36517-91-6.gif) |
Donepezil Impurity 2 |
36517-91-6 |
C11H10O4 |
![Fesoterodine Related Impurity 2](/CAS/20180808/GIF/1254942-29-4.gif) |
Fesoterodine Related Impurity 2 |
1254942-29-4 |
C30H39NO6 |
![Prasugrel Impurity 13 HCl](/CAS/20210111/GIF/1618108-01-2.gif) |
Prasugrel Impurity 13 HCl |
1618108-01-2 |
C18H19ClFNOS |
![Ticagrelor Related Compound 5](/CAS/20200611/GIF/1414348-35-8.gif) |
Ticagrelor Related Compound 5 |
1414348-35-8 |
C9H9F2N |
![Vortioxetine Impurity 2](/CAS/20180808/GIF/1293489-69-6.gif) |
Vortioxetine Impurity 2 |
1293489-69-6 |
C17H20N2S |
![(S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid](/CAS/20180808/GIF/1151893-81-0.gif) |
(S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid |
1151893-81-0 |
C24H21Cl2N3O7S2 |
![Cilastatin ammonium salt](/CAS/20211123/GIF/877674-82-3.gif) |
Cilastatin ammonium salt |
877674-82-3 |
C16H29N3O5S |
![ACETIC ACID 2-METHOXY-4-(5-OXO-2-PHENYL-OXAZOL-4-YLIDENEMETHYL)-PHENYL ESTER](/CAS/20180703/GIF/18692-68-7.gif) |
ACETIC ACID 2-METHOXY-4-(5-OXO-2-PHENYL-OXAZOL-4-YLIDENEMETHYL)-PHENYL ESTER |
18692-68-7 |
C19H15NO5 |
![1,4-di(benzo[b]thiophen-4-yl)piperazine](/CAS/20180703/GIF/1420987-86-5.gif) |
1,4-di(benzo[b]thiophen-4-yl)piperazine |
1420987-86-5 |
C20H18N2S2 |
![(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180703/GIF/1012341-52-4.gif) |
(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-52-4 |
C23H29NO4 |
![DONEPEZIL IMP](/CAS/20210111/GIF/923571-16-8.gif) |
DONEPEZIL IMP |
923571-16-8 |
C24H22NO4.Cl |
![Parecoxib Impurity N](/) |
Parecoxib Impurity N |
|
|
![5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester](/CAS/20180703/GIF/87475-54-5.gif) |
5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
87475-54-5 |
C18H25Cl2N3O2 |
![(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline](/CAS/20200331/GIF/85-63-2.gif) |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline |
85-63-2 |
C21H27NO4 |
![Linagliptin Impurity P](/) |
Linagliptin Impurity P |
|
|
![Linagliptin Impurity U](/) |
Linagliptin Impurity U |
|
|
![(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzoic acid](/CAS/20180703/GIF/1917324-15-2.gif) |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzoic acid |
1917324-15-2 |
C18H21FN4O4 |
![N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide](/CAS/20180703/GIF/CB63042210.gif) |
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide |
|
C40H42F2N10O6 |
![ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate](/CAS/20180703/GIF/618385-10-7.gif) |
ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
618385-10-7 |
C29H33FN2O4 |
![(2R)-2-deoxy-2-fluoro-2-methyl-α/β-D-erythro-pentofuranosyl chloride-3,5-dibenzoate](/CAS/20200611/GIF/1621160-31-3.gif) |
(2R)-2-deoxy-2-fluoro-2-methyl-α/β-D-erythro-pentofuranosyl chloride-3,5-dibenzoate |
1621160-31-3 |
C20H18ClFO5 |
![Etoricoxib Impurity 17](/) |
Etoricoxib Impurity 17 |
|
|
![Ibrutinib Impurity 3](/CAS/20210111/GIF/1226872-27-0.gif) |
Ibrutinib Impurity 3 |
1226872-27-0 |
C25H26N6O4 |
![Imatinib Impurity 2](/CAS/20210111/GIF/1384131-91-2.gif) |
Imatinib Impurity 2 |
1384131-91-2 |
C7H11NO |
![Mirabegron M5 (YM-538852)](/CAS/20200611/GIF/1365244-63-8.gif) |
Mirabegron M5 (YM-538852) |
1365244-63-8 |
C18H22N2O2 |
![Sofosbuvir Impurity 6](/) |
Sofosbuvir Impurity 6 |
|
|
![Vonoprazan Impurity 2](/CAS/20200611/GIF/881733-36-4.gif) |
Vonoprazan Impurity 2 |
881733-36-4 |
C17H16FN3O2S |
![Atomoxetine EP impurity A](/CAS/20180906/GIF/56161-70-7.gif) |
Atomoxetine EP impurity A |
56161-70-7 |
C16H19NO |
![Cinacalcet Impurity 21](/) |
Cinacalcet Impurity 21 |
|
|
![Dasatinib Impurity D](/) |
Dasatinib Impurity D |
|
|
![Doxofylline Impurity 1](/CAS/20200611/GIF/1429636-74-7.gif) |
Doxofylline Impurity 1 |
1429636-74-7 |
C10H16N4O3 |
![Isopropyl4-hydroxy-3,5-diisopropylbenzoate](/CAS/20210111/GIF/2095678-97-8.gif) |
Isopropyl4-hydroxy-3,5-diisopropylbenzoate |
2095678-97-8 |
C16H24O3 |
![Sitagliptin EP Impurity B](/CAS/20180906/GIF/1345822-87-8.gif) |
Sitagliptin EP Impurity B |
1345822-87-8 |
C16H19F5N5O5P |
![Trospium Impurity](/) |
Trospium Impurity |
|
|
![Vildagliptin Related Compound A](/CAS/20200611/GIF/741657-02-3.gif) |
Vildagliptin Related Compound A |
741657-02-3 |
C17H25N3O |
![2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate](/CAS/20180703/GIF/1367369-78-5.gif) |
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate |
1367369-78-5 |
C12H15N5O3 |
![Moxifloxacin Impurity 6](/CAS/20210111/GIF/849770-49-6.gif) |
Moxifloxacin Impurity 6 |
849770-49-6 |
C25H29BFN3O8 |
![Sitafloxacin Impurity A](/CAS/20210111/GIF/500295-83-0.gif) |
Sitafloxacin Impurity A |
500295-83-0 |
C16H16FN3O3 |
![1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/CAS/20180703/GIF/171723-80-1.gif) |
1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
171723-80-1 |
C25H26N2O2 |
![Merariveron impurity C](/) |
Merariveron impurity C |
|
|
![Cefazoline Impurity A](/) |
Cefazoline Impurity A |
|
|
![Rifaximin impurity A](/) |
Rifaximin impurity A |
|
|
![4,5,6,7-Tetrahydro-thieno[3,2-c]pyridin-2-ol 2-acetate](/CAS/20180703/GIF/1151904-85-6.gif) |
4,5,6,7-Tetrahydro-thieno[3,2-c]pyridin-2-ol 2-acetate |
1151904-85-6 |
C9H11NO2S |
![ethyl (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/110548-06-6.gif) |
ethyl (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
110548-06-6 |
C15H13F2NO4 |
![methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20180703/GIF/CB63116218.gif) |
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2097505-01-4 |
C56H54N8O7 |
![Roxithromycin EP Impurity J](/CAS/20180808/GIF/134834-12-1.gif) |
Roxithromycin EP Impurity J |
134834-12-1 |
C40H73ClN2O14 |
![Venlafaxine D6](/CAS/20180703/GIF/CB63116344.gif) |
Venlafaxine D6 |
940297-06-3 |
C17H27NO2 |
![Levosimendan Impurity 3](/) |
Levosimendan Impurity 3 |
|
|
![Sofosbuvir Impurity29](/) |
Sofosbuvir Impurity29 |
|
|
![Levosimendan Impurity 1](/CAS/20210305/GIF/1643439-59-1.gif) |
Levosimendan Impurity 1 |
1643439-59-1 |
C22H23N7O2 |
![Atomoxetine EP Impurity F](/) |
Atomoxetine EP Impurity F |
|
|
![Quetiapine EP Impurity Q](/) |
Quetiapine EP Impurity Q |
|
|
![Cefoxitin Impurity](/) |
Cefoxitin Impurity |
|
|
![ethyl (S)-6,7,8-trifluoro-1-(1-hydroxypropan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate](/CAS/20180703/GIF/110548-03-3.gif) |
ethyl (S)-6,7,8-trifluoro-1-(1-hydroxypropan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate |
110548-03-3 |
C15H14F3NO4 |
![ACT 373898](/CAS/20210111/GIF/1433875-14-9.gif) |
ACT 373898 |
1433875-14-9 |
C15H17BrN4O5S |
![Olaparib Impurity D](/) |
Olaparib Impurity D |
|
|
![1-methylpyrrolidin-3-yl 2-(cyclopentyloxy)-2-phenylacetate](/CAS/20180703/GIF/CB63127223.gif) |
1-methylpyrrolidin-3-yl 2-(cyclopentyloxy)-2-phenylacetate |
|
C18H25NO3 |
![Cabozantinib impurity A](/) |
Cabozantinib impurity A |
|
|
![Loratadine Impurity 2](/CAS/20200331/GIF/CB63127511.gif) |
Loratadine Impurity 2 |
|
C22H23ClN2O2 |
![Metoprolol Impurity 1](/CAS/20200331/GIF/CB63127586.gif) |
Metoprolol Impurity 1 |
|
C15H25NO3 |
![Pitavastatin Impurity 1](/) |
Pitavastatin Impurity 1 |
|
|
![Trifluridine Impurity 3](/) |
Trifluridine Impurity 3 |
|
|
![Vonoprazan Impurity 1](/) |
Vonoprazan Impurity 1 |
|
|
![Vonoprazan Impurity 4](/) |
Vonoprazan Impurity 4 |
|
|
![Cinacalcet impurity K](/) |
Cinacalcet impurity K |
|
|
![Valsartan Impurity 13](/CAS/20200331/GIF/CB63128109.gif) |
Valsartan Impurity 13 |
|
C24H29N5O3 |
![Valsartan Impurity 27](/CAS/20180703/GIF/CB63128114.gif) |
Valsartan Impurity 27 |
|
C24H29N5O3 |
![Etoricoxib Impurity 6](/) |
Etoricoxib Impurity 6 |
|
|
![Ezetimibe impurity 3](/) |
Ezetimibe impurity 3 |
|
|
![bis(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate](/CAS/20180703/GIF/CB63128396.gif) |
bis(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
166808-97-5 |
C16H16N2O6 |
![Ticagrelor Imp.J](/CAS/20210305/GIF/2248538-63-6.gif) |
Ticagrelor Imp.J |
2248538-63-6 |
C14H20ClN5O4S |
![Vortioxetine Imp.E](/CAS/20200515/GIF/508233-77-0.gif) |
Vortioxetine Imp.E |
508233-77-0 |
C18H22N2S |
![(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one](/CAS/20180703/GIF/1700622-07-6.gif) |
(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-07-6 |
C25H24FNO3 |
![Topiroxostat Impurity 1](/) |
Topiroxostat Impurity 1 |
|
|
![Oxcarbazepine Impurity3](/) |
Oxcarbazepine Impurity3 |
|
|
![Mosapride IMP](/) |
Mosapride IMP |
|
|
![4-Ethoxy Paroxetine](/CAS/20200611/GIF/606968-04-1.gif) |
4-Ethoxy Paroxetine |
606968-04-1 |
C21H25NO4 |
![Methylene-Bis Paroxetine](/CAS/20211123/GIF/1292846-10-6.gif) |
Methylene-Bis Paroxetine |
1292846-10-6 |
C39H40F2N2O6 |
![Trelagliptin Impurity X](/CAS/20200611/GIF/1938080-44-4.gif) |
Trelagliptin Impurity X |
1938080-44-4 |
C18H22FN5O3 |
![Cefoxitin Sodium impurity](/) |
Cefoxitin Sodium impurity |
|
|
![2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester](/CAS/20180703/GIF/1455091-06-1.gif) |
2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester |
1455091-06-1 |
C25H25NO7S |
![(1R,3S)-(3-Aminocyclopentyl) methanol](/CAS/20180703/GIF/117957-62-7.gif) |
(1R,3S)-(3-Aminocyclopentyl) methanol |
117957-62-7 |
C6H13NO |
![Canagliflozin Impurity 12](/) |
Canagliflozin Impurity 12 |
|
|
![Canagliflozin Impurity G](/) |
Canagliflozin Impurity G |
|
|
![Dolutegravir Impurity 1](/) |
Dolutegravir Impurity 1 |
|
|
![Empagliflozin impurity F](/) |
Empagliflozin impurity F |
|
|
![Ibrutinib Impurity 12](/) |
Ibrutinib Impurity 12 |
|
|
![Nintedanib impurity J](/CAS/20210111/GIF/1139457-10-5.gif) |
Nintedanib impurity J |
1139457-10-5 |
C23H17N3O5 |
![DSKNHVUKATXSCQ-GDVCOKDOSA-N](/CAS/20210111/GIF/188915-50-6.gif) |
DSKNHVUKATXSCQ-GDVCOKDOSA-N |
188915-50-6 |
C14H14ClN3O4S |
![Clarthromycin EP Impurity B](/CAS/20210111/GIF/299409-85-1.gif) |
Clarthromycin EP Impurity B |
299409-85-1 |
C37H67NO13 |
![(4-Chloro-3-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester](/CAS/20200401/GIF/352277-93-1.gif) |
(4-Chloro-3-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester |
352277-93-1 |
C12H13ClF3NO2 |
![Edoxaban Impurity 16](/CAS/20180906/GIF/480450-69-9.gif) |
Edoxaban Impurity 16 |
480450-69-9 |
C14H25N5O3 |
![Rivaroxaban Impurity 24](/) |
Rivaroxaban Impurity 24 |
|
|